By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is largely bearish on Astera Labs (ALAB), citing its high valuation (105x forward earnings), potential execution risks, and the cyclical nature of semi-cap spending. While the company's recent revenue growth and Scorpio X switch launch are promising, the panelists express concerns about competition, customer concentration, and the risk of a disorderly AI slowdown.
Risk: A disorderly AI slowdown or a rapid vertical integration by hyperscalers leading to the obsolescence of Scorpio X.
Opportunity: Rapid market share gain or Scorpio X becoming the de facto AI fabric standard, which could re-rate ALAB's multiple.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Astera Labs reported a terrific first quarter.
The company also introduced a new networking fabric switch, which Astera believes will be its largest product this year.
A Wall Street analyst hiked his price target by $82.
Shares of AI connectivity provider Astera Labs (NASDAQ: ALAB) rallied 76.1% in May, according to data from S&P Global Market Intelligence.
Astera has become one of the leading names in connectivity for artificial intelligence systems, as networking between servers, chips, and memory is increasingly important in the age of agentic AI.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Thus, it's no surprise Astera rose last month, as it reported strong earnings and gave a bullish outlook amid a strong month for AI chip stocks generally.
In its fiscal first quarter, Astera Labs saw revenue jump 93.5% to $308.4 million, with adjusted (non-GAAP) earnings jumping 84.8% to $0.61. Both figures handily beat analyst estimates. Management also strongly guided to $360 million in revenue at the midpoint for the current quarter, which would amount to very strong 26% quarter-over-quarter growth.
Aside from the strong results, Astera stock jumped again on May 19, rising over 17% at one point on the day, after the company presented at an industry conference and a sell-side analyst raised its price target.
At the J.P. Morgan Global Technology, Media and Communications Conference, CEO Jitendra Mohan gave very positive commentary on the company's growth outlook, particularly the ramp for Astera's new data center switch chipset, the Scorpio X fabric switch. Mohan said the product should ramp to become the company's largest product by sales by the end of the year. That's an exciting feat, given that Astera just introduced the Scorpio X in early May.
That same day, tech analysts at Evercore ISI raised the firm's price target on Astera shares from $215 to $297. The analysts cited positive channel checks, noting that the progression of agentic AI is placing an onus on low-cost-per-token inference, which requires several types of chips, not just expensive training-oriented GPUs. The optimization across GPUs, CPUs, ASICs, and memory requires ever-increasing connectivity, which benefits Astera's product portfolio.
Astera is up 250% over the past year, and currently trades at a lofty 105 times this year's earnings estimates. Like several other semiconductor stocks that produce GPUs, CPUs, memory, connectivity, or the machines that build these chips, just about every company exposed to the agentic AI build-out has had a fantastic year.
Still, at these levels, valuations are quite high, and a pullback is to be expected. One might have begun, in fact, on Friday. That being said, Astera should be a part of any investor's "basket" of AI beneficiaries to buy on any large dips.
That's because the AI build-out seems set to continue. Given the massiveinvestment newswe have seen recently, including Alphabet's announcement that it will raise $80 billion in stock to fund its AI build-out, the chip bull market seems set to continue over the next couple of years.
Before you buy stock in Astera Labs, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Astera Labs wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 6, 2026. *
JPMorgan Chase is an advertising partner of Motley Fool Money. Billy Duberstein and/or hsi clients have positions in Alphabet. The Motley Fool has positions in and recommends Alphabet and JPMorgan Chase. The Motley Fool recommends Astera Labs. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Astera's very high valuation makes the upside highly contingent on a rapid, durable Scorpio X ramp and sustained AI capex, otherwise a meaningful multiple re-rating to reflect execution risk is likely."
Astera's May surge is anchored in a single-quarter beat and a bullish AI hardware narrative. Yet the rally rests on open questions: can Scorpio X truly become the largest product by year-end, and can AI infrastructure spend stay above cycle for 12–18 months? The stock trades around 105x forward earnings, leaving little cushion for missed guidance or margin pressure as competition intensifies. The article glosses over execution risk (chip, packaging, channel Mumbai? actually channel delays), potential customer concentration, and the risk that AI demand cools if cloud capex moderates. Without a timely Scorpio X ramp and stable margins, upside may prove fragile and downside could hit faster than expected.
Bull cases would argue the AI build-out is durable and Astera has a scalable moat; if channel checks and customer demand hold, Scorpio X could catalyze further upside despite high valuations.
"The current valuation of 105x forward earnings leaves zero room for execution error in the ramp-up of the Scorpio X switch, making the stock highly vulnerable to a sharp correction."
Astera Labs (ALAB) is currently priced for perfection, trading at an eye-watering 105x forward earnings. While the 93.5% revenue growth is impressive, the market is essentially pricing in an aggressive, multi-year dominance in the 'AI connectivity' niche. The pivot toward the Scorpio X fabric switch is a high-stakes gamble; if this product faces any manufacturing delays or fails to capture significant market share from incumbents like Broadcom or Marvell, the valuation will compress violently. Investors are ignoring the cyclical nature of semi-cap spending. While the AI infrastructure build-out is real, paying such a massive premium for a company that is essentially a high-growth utility provider for Nvidia's ecosystem is dangerous.
If Astera’s connectivity chips become the de facto standard for all hyperscale AI clusters, the 105x multiple may prove to be a bargain relative to the long-term total addressable market expansion.
"Astera's 105x forward earnings leaves little margin for error if AI infrastructure spending decelerates."
Astera Labs' 93.5% revenue jump to $308.4M and Scorpio X switch launch position it well in AI connectivity, yet the 105x forward earnings multiple after a 250% yearly gain leaves scant room for disappointment. The 26% QoQ revenue guide and Evercore's $297 target hinge on agentic AI driving sustained connectivity demand, but this ignores typical semiconductor cycle risks where capex peaks trigger sharp multiple compression. Alphabet's planned $80B AI spend provides a near-term tailwind, yet execution delays or broader GPU spending saturation could quickly pressure shares. Focus on whether the new chipset truly scales to become the top product by year-end.
The 105x multiple could compress upward if channel checks confirm accelerating inference demand and Scorpio X ramps faster than expected, justifying re-rating toward peers with similar growth trajectories.
"ALAB's valuation assumes Scorpio X becomes a multi-billion-dollar franchise within 12 months; the stock has already priced in success, leaving little margin for execution risk."
ALAB's 76% May rally rests on two pillars: Q1 beat (93.5% revenue growth, $0.61 EPS vs. estimates) and Scorpio X hype. But the 105x forward P/E is not a valuation—it's a confession of priced-in perfection. The article conflates 'AI needs connectivity' (true) with 'ALAB captures that value' (unproven). Scorpio X ramping to largest product by year-end is management guidance, not booked revenue. Evercore's $297 target assumes agentic AI's inference-optimization thesis plays out exactly as modeled. The real risk: if data center capex cycles cool, or if hyperscalers vertically integrate switching fabric (as they've done with custom silicon), ALAB's TAM compresses fast.
At 105x forward earnings with a product that just launched, ALAB is pricing in 3–5 years of flawless execution and market share gains against entrenched competitors (Broadcom, Marvell). One miss on Scorpio X adoption or a single quarter of guidance cut could trigger a 40–50% reversion.
"Scorpio X fast ramp or standardization could re-rate ALAB despite current capex-cycle worries."
Responding to Gemini: You’re right that 105x prices in perfection, but you miss optionality. If Scorpio X gains share rapidly or becomes the de facto AI fabric standard, ALAB’s multiple could re-rate even amid cyclical capex concerns. The bigger risk is a disorderly AI slowdown; but if hyperscalers double down, the TAM expansion could outpace the cycle. Your bear case hinges on a slower ramp and competitor wins—quantify probability?
"The primary risk to ALAB is not just market share loss to incumbents, but architectural obsolescence if hyperscalers standardize on proprietary, vertically integrated interconnects."
Gemini and Claude ignore the 'Nvidia-as-a-service' dynamic. ALAB isn't just a utility; it is a critical bottleneck-reliever for GPU clusters. If hyperscalers like Google or Meta move to vertical integration, they likely target the ASIC, not the connectivity fabric, which requires massive interoperability. The risk isn't just 'competition' from Broadcom; it is the potential for architectural shifts that render external retimers obsolete. We must watch for proprietary interconnect standards that bypass third-party switching silicon entirely.
"Hyperscalers may commoditize connectivity fabric after ASICs, accelerating ALAB's obsolescence risk beyond current discussion."
Gemini flags vertical integration risk but misses that connectivity fabric is often the first layer hyperscalers commoditize after ASICs. If Meta or Google standardize on proprietary interconnects like NVLink extensions, Scorpio X faces obsolescence faster than Broadcom competition. This connects directly to ChatGPT's customer concentration concern—losing even one major client to in-house solutions could crater the 105x multiple before any capex slowdown materializes.
"Vertical integration risk is real, but the margin pressure from Scorpio X commoditization may hit before any customer loss does."
Grok and Gemini both flag vertical integration risk, but conflate two different threats. Hyperscalers building custom interconnects (NVLink extensions) is real; losing customers to in-house solutions is real. But Scorpio X's value isn't interoperability—it's retiming latency across fabric. That's harder to internalize than an ASIC. The actual risk: does Scorpio X solve a problem hyperscalers care enough to pay premium pricing for, or is it table-stakes margin compression? Nobody's quantified Astera's gross margin trajectory post-Scorpio ramp.
The panel is largely bearish on Astera Labs (ALAB), citing its high valuation (105x forward earnings), potential execution risks, and the cyclical nature of semi-cap spending. While the company's recent revenue growth and Scorpio X switch launch are promising, the panelists express concerns about competition, customer concentration, and the risk of a disorderly AI slowdown.
Rapid market share gain or Scorpio X becoming the de facto AI fabric standard, which could re-rate ALAB's multiple.
A disorderly AI slowdown or a rapid vertical integration by hyperscalers leading to the obsolescence of Scorpio X.